Research Interests

• The effects of aging, cardiovascular and metabolic risk factors, and habitual physical activity on vascular endothelial function (e.g. nitric oxide bioavailability and thromboresistance).
• Integrative Vascular Biology Laboratory (IVB Lab)

• 1987-1991, B.S.,Biology (minor, Computer Science), Eastern Mennonite University, Harrisonburg, VA
• 1993-1994, Howard Hughes Medical Student Research Training Fellowship under the guidance of Russell L. Moore, Ph.D., Professor of Kinesiology and Applied Physiology, University of Colorado, Boulder, CO and Joseph Y. Cheung, M.D., Ph.D., Professor of Medicine & Cellular & Molecular Physiology, Penn State University, College of Medicine.
• 1991-1996, M.D. (conferred May 19, 1996), The Penn State University College of Medicine, Milton S. Hershey Medical Center, Hershey, PA

• 1996-1999, Internal Medicine Training Program, University Hospitals of Cleveland, Cleveland, OH. Board Eligible in Internal Medicine July 1, 1999. Board Certified in Internal Medicine October, 1999.
• 1999-2005, Clinical Fellow, Cardiology Fellowship Training Program University of Colorado Health Sciences Center, Denver, CO.
• 2000-2005, Instructor, Department of Medicine University of Colorado Health Sciences Center, Denver, CO.
• 2000-present, Medical Director, Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, CO.
• 2005-present, Assistant Professor, Department of Medicine, Division of Cardiology, Denver Health and University of Colorado at Denver and the Health Sciences Center, Denver, CO.

• Weil BR, MacEneaney OJ, Stauffer BL , DeSouza CA. Habitual short sleep duration and circulating endothelial progenitor cells. Journal of Cardiovascular Disease Research, Apr;2(2): 110-114, 2011.


• Stauffer BL, Sobus RD, Sucharov CC. Sex differences in cardiomyocyte connexin43 expression. Journal of Cardiovascular Pharmacology. Jul;58(1): 32-39, 2011.


• Kushner EJ, MacEneaney OJ, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Aging is associated with a proapoptotic endothelial progenitor cell phenotype. Journal of Vascular Research, May 31;48(5): 408-414, 2011.


• Luczak ED, Barthel KK, Stauffer BL, Konhilas JP, Cheung TH, einwand LA. Remodeling the cardiac transcriptional landscape with diet. Physiological Genomics, Jun 28;43(12): 772-780, 2011.


• Westby CM, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilation in men. Clinical Science (London), Jun;120(11): 485-491, 2011.

• Weil BR, Mestek ML, Greiner JJ, Stauffer BL, DeSouza CA. Increased endothelin-1 vasoconstictor tone with prehypertension. The Journal of Clinical Hypertension. 13(1): A33, 2011. Presented at the American Society of Hypertesnsion 2011 Annual Scientific Meeting at Exposition, New York, NY, May 2011.


• Weil BR, Mestek ML, Greiner JJ, Stauffer BL, DeSouza CA. Prehypertension is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation. Presented at Arteriosclerosis, Thrombosis and Vascular Biology 2011 Scientific Sessions, Chicago, IL, April 2011.


• Diehl KJ, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Impaired nitric oxide-mediated endothelium-dependent vasodilation with suboptimal LDL cholesterol. FASEB Journal. 25: 1103.5, 2011. Presented at Experimental Biology, Washington, D.C. April, 2011.


• Templeton DL, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. C-reactive protein-related endothelial vasodilator dysfunction in healthy adults. FASEB Journal. 25:821.34, 2011. Presented at Experimental Biology, Washington, D.C. April, 2011. *Recipient of the 2011 Caroline tum Suden /Francis Hellebrandt Professional Opportunity Award


• Diehl KJ, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Impaired nitric oxide-mediated endothelium-dependent vasodilation with suboptimal LDL cholesterol. FASEB Journal. 25; 1103.5, 2011. Presented at Experimental Biology, Washington, D.C. April, 2011.


• Diehl KJ, Connick E, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Accelerated vascular aging with HIV-1 infection regardless of antiretroviral therapy status. Presented at the 17th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011.